OAKVILLE, ON, Feb. 4, 2019 /CNW/ - Takeda Canada Inc. is proud to announce that it has been certified and recognized by the Top Employers Institute for the second consecutive year for its exceptional employee offerings.
Organizations certified as Top Employers dedicate themselves to providing the very best working environment for employees through their progressive 'people-first' human resources practices. The criteria assessed for the recognition include: talent strategy, workforce planning, talent acquisition, on-boarding, learning and development, performance management, leadership development, career and succession management, compensation and benefits, and culture. Takeda Canada Inc. was awarded the exclusive Top Employers certification for Canada and for North America in 2018 and again received this recognition for 2019.
"It's an honour for Takeda Canada to receive this recognition. This global certification program is a validation of the excellent policies Takeda has in place for employees to thrive in their job and to achieve a work life balance," said Gamze Yüceland, General Manager of Takeda Canada. "We are working very hard at Takeda Canada to ensure that we have employee satisfaction. We truly believe when an employee feels valued, they will take pride in the work they do."
The Top Employers Institute globally certifies excellence in the conditions that employers create for their people. Crucial to the Top Employers process is that participating companies must complete a stringent research process and meet the required high standard to achieve the certification. To further reinforce the validity of the process, all results were independently audited, meaning this research has verified the outstanding employee conditions at Takeda Canada and earned the company a coveted spot among a select group of certified Top Employers.
For more information about the Top Employers certification process, visit top-employers.com.
About Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience, and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.
For more information, visit https://www.takeda.com
About Takeda Canada
Takeda Canada headquarters is currently located in Oakville, Ontario. The Oakville and Toronto offices comprise the Canadian sales and marketing organization of Takeda Pharmaceutical Company Limited. Takeda Canada is delivering better health for Canadians through leading innovations in gastroenterology, oncology, neuroscience, and rare diseases. Additional information about Takeda Canada is available at takeda.com/en-ca.
SOURCE Takeda Canada Inc.
For further information: Media Contact: Amanda Jacobs, firstname.lastname@example.org, + 647-923-6479